294 related articles for article (PubMed ID: 27082952)
1. Ginsenoside Rg1 ameliorates hippocampal long-term potentiation and memory in an Alzheimer's disease model.
Li F; Wu X; Li J; Niu Q
Mol Med Rep; 2016 Jun; 13(6):4904-10. PubMed ID: 27082952
[TBL] [Abstract][Full Text] [Related]
2. Chronic treatment with ginsenoside Rg1 promotes memory and hippocampal long-term potentiation in middle-aged mice.
Zhu G; Wang Y; Li J; Wang J
Neuroscience; 2015 Apr; 292():81-9. PubMed ID: 25724866
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg1 attenuates amyloid-beta content, regulates PKA/CREB activity, and improves cognitive performance in SAMP8 mice.
Shi YQ; Huang TW; Chen LM; Pan XD; Zhang J; Zhu YG; Chen XC
J Alzheimers Dis; 2010; 19(3):977-89. PubMed ID: 20157253
[TBL] [Abstract][Full Text] [Related]
4. Effects of ginsenoside Rg1 or 17β-estradiol on a cognitively impaired, ovariectomized rat model of Alzheimer's disease.
Zhang X; Wang J; Xing Y; Gong L; Li H; Wu Z; Li Y; Wang J; Wang Y; Dong L; Li S
Neuroscience; 2012 Sep; 220():191-200. PubMed ID: 22728092
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg1 Ameliorates Behavioral Abnormalities and Modulates the Hippocampal Proteomic Change in Triple Transgenic Mice of Alzheimer's Disease.
Nie L; Xia J; Li H; Zhang Z; Yang Y; Huang X; He Z; Liu J; Yang X
Oxid Med Cell Longev; 2017; 2017():6473506. PubMed ID: 29204248
[TBL] [Abstract][Full Text] [Related]
6. [Effect of ginsenoside Rg1 on expressions of phosphory protein tau and N-methyl-D-aspartate receptor subunits NR1 and NR2B in rat brain slice model of Alzheimer's disease].
Li X; Liu Y; Zhang X; Yuan H; Quan Q
Zhongguo Zhong Yao Za Zhi; 2010 Dec; 35(24):3339-43. PubMed ID: 21438403
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rg1 reduces β‑amyloid levels by inhibiting CDΚ5‑induced PPARγ phosphorylation in a neuron model of Alzheimer's disease.
Quan Q; Li X; Feng J; Hou J; Li M; Zhang B
Mol Med Rep; 2020 Oct; 22(4):3277-3288. PubMed ID: 32945455
[TBL] [Abstract][Full Text] [Related]
8. Treadmill exercise prevents decline in spatial learning and memory in APP/PS1 transgenic mice through improvement of hippocampal long-term potentiation.
Liu HL; Zhao G; Cai K; Zhao HH; Shi LD
Behav Brain Res; 2011 Apr; 218(2):308-14. PubMed ID: 21192984
[TBL] [Abstract][Full Text] [Related]
9. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.
Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J
Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/Akt.
Shi C; Zheng DD; Fang L; Wu F; Kwong WH; Xu J
Biochim Biophys Acta; 2012 Apr; 1820(4):453-60. PubMed ID: 22178929
[TBL] [Abstract][Full Text] [Related]
11. Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model.
Fang F; Chen X; Huang T; Lue LF; Luddy JS; Yan SS
Biochim Biophys Acta; 2012 Feb; 1822(2):286-92. PubMed ID: 22015470
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rg1 ameliorates the cognitive deficits in D-galactose and AlCl
Zhong SJ; Wang L; Gu RZ; Zhang WH; Lan R; Qin XY
Int J Med Sci; 2020; 17(8):1048-1055. PubMed ID: 32410834
[TBL] [Abstract][Full Text] [Related]
13. Rg1 exhibits neuroprotective effects by inhibiting the endoplasmic reticulum stress-mediated c-Jun N-terminal protein kinase apoptotic pathway in a rat model of Alzheimer's disease.
Mu JS; Lin H; Ye JX; Lin M; Cui XP
Mol Med Rep; 2015 Sep; 12(3):3862-3868. PubMed ID: 26016457
[TBL] [Abstract][Full Text] [Related]
14. Synaptic modification by L-theanine, a natural constituent in green tea, rescues the impairment of hippocampal long-term potentiation and memory in AD mice.
Zhu G; Yang S; Xie Z; Wan X
Neuropharmacology; 2018 Aug; 138():331-340. PubMed ID: 29944861
[TBL] [Abstract][Full Text] [Related]
15. AVP(4-8) Improves Cognitive Behaviors and Hippocampal Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease.
Zhang X; Zhao F; Wang C; Zhang J; Bai Y; Zhou F; Wang Z; Wu M; Yang W; Guo J; Qi J
Neurosci Bull; 2020 Mar; 36(3):254-262. PubMed ID: 31605298
[TBL] [Abstract][Full Text] [Related]
16. Long-term ginsenoside administration prevents memory loss in aged female C57BL/6J mice by modulating the redox status and up-regulating the plasticity-related proteins in hippocampus.
Zhao HF; Li Q; Li Y
Neuroscience; 2011 Jun; 183():189-202. PubMed ID: 21463662
[TBL] [Abstract][Full Text] [Related]
17. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
18. Minor ginsenoside F1 improves memory in APP/PS1 mice.
Han J; Oh JP; Yoo M; Cui CH; Jeon BM; Kim SC; Han JH
Mol Brain; 2019 Sep; 12(1):77. PubMed ID: 31488185
[TBL] [Abstract][Full Text] [Related]
19. High-throughput metabolomics and ingenuity pathway approach reveals the pharmacological effect and targets of Ginsenoside Rg1 in Alzheimer's disease mice.
Li G; Zhang N; Geng F; Liu G; Liu B; Lei X; Li G; Chen X
Sci Rep; 2019 May; 9(1):7040. PubMed ID: 31065079
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rg1 decreases Aβ(1-42) level by upregulating PPARγ and IDE expression in the hippocampus of a rat model of Alzheimer's disease.
Quan Q; Wang J; Li X; Wang Y
PLoS One; 2013; 8(3):e59155. PubMed ID: 23520555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
